← Leaderboards
Ian J Davis
Univ Of North Carolina Chapel Hill
$7,130,869
Attributed
$11,851,831
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,851,831 · 8
By mechanism
R01$6,810,823 · 4
T32$2,890,041 · 1
R33$1,094,763 · 1
K08$684,170 · 1
R21$372,034 · 1
Top collaborators
- Samantha Gail Pattenden8 shared
- Wendy K Rathmell7 shared
- Brian D Strahl7 shared
- Kanecia Obie Zimmerman5 shared
- Paul A Dayton3 shared
- Pengda Liu2 shared
- Sallie R. Permar1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Brian D Strahl$12,633,933
- Dirk P Dittmer$32,603,888
- Taylor Joel Richard Penke$84,191
- Pengda Liu$3,650,940
- Catherine Fahey$147,667
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorChromatinMalignant NeoplasmsProgramsMutationHistonesBaseNeoplastic CellGenesNucleosomesGenomicsEpigenetic ProcessMediatingEventPatternHistone ModificationRenal Cell CarcinomaRegulationProteinsTranscription FactorPathway InteractionsFormaldehydeMutateOncogenic
Grant awards (39)
Unified Program for Therapeutics in Children$432,643
T32 · FY2025 · HD
Developmental control of chromatin states in cancer$424,710
R01 · FY2025 · CA · contact PI
Developmental control of chromatin states in cancer$414,512
R01 · FY2024 · CA · contact PI
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research$400,467
R01 · FY2024 · GM
Developmental control of chromatin states in cancer$411,481
R01 · FY2023 · CA · contact PI
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research$400,726
R01 · FY2023 · GM
Unified Program for Therapeutics in Children (UPTiC)$361,054
T32 · FY2023 · HD
Unified Program for Therapeutics in Children (UPTiC)$559,026
T32 · FY2022 · HD
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research$400,961
R01 · FY2022 · GM
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research$52,847
R01 · FY2022 · GM
Unified Program for Therapeutics in Children (UPTiC)$507,132
T32 · FY2021 · HD
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical research$401,503
R01 · FY2021 · GM
Unified Program for Therapeutics in Children (UPTiC)$528,081
T32 · FY2020 · HD
Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma$202,928
R21 · FY2020 · CA
Unified Program for Therapeutics in Children (UPTiC)$502,105
T32 · FY2019 · HD
Chromatin maintenance in cancer progression$446,600
R01 · FY2019 · CA
The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues$359,003
R33 · FY2019 · CA
Targeting EWS-FLI1 protein stability as therapeutic strategy for Ewing sarcoma$169,106
R21 · FY2019 · CA
Chromatin maintenance in cancer progression$459,749
R01 · FY2018 · CA
The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues$370,351
R33 · FY2018 · CA
The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues$365,409
R33 · FY2017 · CA
Chromatin maintenance in cancer progression$362,158
R01 · FY2017 · CA
Chromatin maintenance in cancer progression$459,687
R01 · FY2016 · CA
Chromatin organization and transcription factor targeting in cancer$304,426
R01 · FY2016 · CA · contact PI
Chromatin maintenance in cancer progression$97,197
R01 · FY2016 · CA
Chromatin organization and transcription factor targeting in cancer$304,426
R01 · FY2015 · CA · contact PI
Chromatin maintenance in cancer progression$254,979
R01 · FY2015 · CA
Chromatin maintenance in cancer progression$217,376
R01 · FY2015 · CA
Chromatin organization and transcription factor targeting in cancer$15,805
R01 · FY2015 · CA · contact PI
Chromatin organization and transcription factor targeting in cancer$295,293
R01 · FY2014 · CA · contact PI
Chromatin organization and transcription factor targeting in cancer$54,723
R01 · FY2014 · CA · contact PI
Chromatin organization and transcription factor targeting in cancer$286,160
R01 · FY2013 · CA · contact PI
Chromatin organization and transcription factor targeting in cancer$40,611
R01 · FY2013 · CA · contact PI
Chromatin organization and transcription factor targeting in cancer$304,426
R01 · FY2012 · CA · contact PI
MiT Transcription Factor Family in Pediatric Solid Tumor$136,890
K08 · FY2008 · CA · contact PI
MiT Transcription Factor Family in Pediatric Solid Tumor$136,890
K08 · FY2007 · CA · contact PI
MiT Transcription Factor Family in Pediatric Solid Tumor$136,890
K08 · FY2006 · CA · contact PI
MiT Transcription Factor Family in Pediatric Solid Tumor$136,890
K08 · FY2005 · CA
MiT Transcription Factor Family in Pediatric Solid Tumor$136,610
K08 · FY2004 · CA